Navigation Links
University of Massachusetts Medical School Opens New Center for FSHD Research and Training
Date:11/15/2013

Boston, Massachusetts (PRWEB) November 15, 2013

A new cooperative research center focusing on Facioscapulohumeral Muscular Dystrophy (FSHD) has been established at the University of Massachusetts Medical School (UMMS). The National Institutes of Health Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center will focus its research and training programs on FSHD, one of the most prevalent myopathies affecting both children and adults.

The Wellstone Center at UMMS will collaborate with the FSH Society, a world leader in combating FSHD that helps connect patients and families with clinical centers across the country. FSH Society President and CEO Daniel Paul Perez was a leading figure in the early advocacy efforts around FSHD and co-authored the MD CARE Act bill and helped compete for the initial $9 million in NIH funding for the UMMS Wellstone Center. Perez, who himself has FSHD, has been a national leader for patients with FSHD over the last thirty years.

There are currently no clinical trials of novel therapeutics for FSHD ongoing in the United States because of a lack of relevant preclinical data to direct development of therapeutic targets to disease mechanisms. The Wellstone Center seeks to change that.

“FSHD leads to severe muscle weakness and our Center's therapeutic approaches will focus on development of drugs that target disease genes, as well as drugs that improve muscle strength,” says Center Director Charles P. Emerson Jr, PhD, professor of cell & developmental biology and neurology. “The therapeutic approaches being developed by our center will have broad application to the treatment of other muscular dystrophies and other debilitating medical conditions of muscle weakness including aging, muscle injury and confined bed rest.”

“The new partnership between the Wellstone Center and other translational research groups at UMMS, such as the Department of Neurology and the Gene Therapy Center, have given the programs another opportunity to bring their unique talents to bear on a vexing clinical problem,” said Terence R. Flotte, MD, executive deputy chancellor, provost and dean of the school of medicine. “This is an important addition to the translational research enterprise.”

The UMMS Center’s mission includes training the next generation of muscular dystrophy clinical and basic researchers, and providing the broader research community with biomaterials for muscular dystrophy research. An important new initiative for the Center will be the establishment of an FSHD clinic, which will serve patients in the region and enable them to participate in research and clinical trials. The partnership between FSHD patients, their families, Center scientists, clinicians and the overall industry will be essential for the Center to successfully carry out its mission to develop therapies for FSHD and other debilitating muscle diseases.

Additionally, the Center supports an Education and Training Core that will oversee a pre- and postdoctoral fellowship program designed to mentor young scientists for careers in skeletal muscle and muscular dystrophy research, with a strong focus on multidisciplinary training for FSHD and muscle disease research. A Cell Core laboratory, with a repository of muscle tissue and cells, will perform genomic studies to establish FSHD biomarkers and will make cell lines available to investigators worldwide for testing new FSHD therapeutics.

The FSH Society will work directly with Wellstone Center leadership to consult on key communications, organize patient and research meetings and workshops, and provide education and support for patients and families participating in the Center’s studies.

The UMMS Wellstone Center is one of six centers funded by the National Institutes of Health, with additional funding from foundations and individuals. These centers engage in translational research with patients and industry to develop novel therapies for muscular dystrophies – genetic diseases resulting in the degeneration of muscle or muscle function. A 2001 federal law, called the MD CARE Act, directed the NIH to establish centers of excellence for research on muscular dystrophy; the program was subsequently named in honor of the late Senator Paul D. Wellstone of Minnesota, a champion of the NIH and muscular dystrophy research.

# # #

About the FSH Society
The FSH Society, founded in 1991 by two FSHD patients, is a world leader in combating muscular dystrophy. The non-profit has provided millions of dollars in seed grants to pioneering research worldwide, creating an international collaborative network of patients and researchers. The FSH Society seeks to serve as a source of information and support for all patients and families with FSHD; act as a driving force in the development of research directed towards treatments and ultimately a cure; and bring support to patients and research for FSHD through effective engagement of governmental and private sector organizations and entities. For five consecutive years, the Society has received the Charity Navigator’s four-star rating, the highest distinction held by less than four percent of non-profit organizations in the country. The FSH Society offers a community of support, news and information for FSHD patients and families through its website at http://www.fshsociety.org. For more information about FSHD, please contact the Society at 781-301-6649.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11338086.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. University of Cincinnati researchers win $3.7M grant from US Department of Defense
2. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
3. Rice University student engineers automate limb lengthening for kids
4. Louisiana Tech University professor earns NSF Early Career Development grant
5. Neuropsychologist receives University of Houstons highest faculty honor
6. University of Houston Graduate College of Social Work announces partnership with MD Anderson
7. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
8. University of Minnesota startup to treat challenging bacterial infection
9. University studies and career expectations of medical students
10. McMaster University researchers discover drug destroys human cancer stem cells but not healthy ones
11. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and its affiliated ... , Gary D. Radine, who recently retired as president and CEO of Delta Dental ... 2015 CEO of the Year , helped lead the effort to raise funds for ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of organizations. DocuSyst provides a cloud hosted environment for FileHold software that ... integration with various 3rd party applications using the FileHold web services API. DocuSyst ...
(Date:2/8/2016)... ... 08, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to a ... derived from a cluster of melanin when exposed to sunlight. Although most moles are ... lifetime of embarrassment. Historically, mole removal has involved a painful, often expensive ...
(Date:2/8/2016)... ... , ... According to research by the National Association of ... be certified or obtain continuing education. To increase patient awareness of the lack ... campaign to inform dentists and patients about the possible lack of skills and ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... Facial Plastics, has added Kybella® to his medical and surgical expertise. Technically known ... approved FDA injectable medication used as a non-surgical alternative for reduction of fat ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... HEIGHTS, Utah , Feb. 8, 2016 /PRNewswire/ ... and distributor of advanced-technology medical devices and rehabilitation ... related markets, congratulates the Denver Broncos, football team ... Kelvyn H. Cullimore Jr. , Chairman and Chief ... of excellence and we look forward to enhancing ...
(Date:2/8/2016)... 2016 --> ... Allied Market Research titled, "World Synthetic Biology ... estimates the world synthetic biology market to be ... technology segment would continue to lead the market ... collectively, held around half of the market share ...
(Date:2/5/2016)... OAKS, Calif. , Feb. 5, 2016 Amgen ... 5 th Annual Global Healthcare Conference at 9:15 a.m. ... York City . David W. Meline , executive ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...
Breaking Medicine Technology: